Immunomodulation by Quillaja saponaria adjuvant formulations: In vivo stimulation of interleukin 12 and its effects on the antibody response

Cytokine

Volumn 9, Issue 2, 1997, Pages 73-82

  Villacres Eriksson, Maria ^a,b   Behboudi, Shahriar ^c   Morgan, Andrew J ^c   Trinchieri, Giorgio ^c   Morein, Bror ^c  

^a BMC Box 574   (Sweden)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NONE

Author keywords

Adjuvant; Immunomodulation; Interleukin 12; Iscoms

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; INTERLEUKIN 4; MONOCLONAL ANTIBODY; VACCINE; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG FORMULATION; HELPER CELL; IMMUNOMODULATION; INFLUENZA VIRUS; MOUSE; NONHUMAN; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031081461     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0139     Document Type: Article

References (45)

1. 1. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-2357.
2. 2. Mahon BP, Katrak K, Nomoto A, Macadam AJ, Minor PD, Mills KH (1995) Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J Exp Med 181:1285-1292.
3. 3. Orange JS, Wolf SF, Biron CA (1994) Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol 152:1253-1264.
4. 4. Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, Shearer GM (1993) Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262:1721-1724.
5. 5. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL (1991) Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277-279.
6. 6. Heinzel FP, Sadick MD, Mutha SS, Locksley RM (1991) Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 88:7011-7015.
7. 7. Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG (1993) Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 177:1797-1802.
8. 8. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayasi M, Young D, Nickbarg E, Chizzonite R, Wolf SF, Trinchieri G (1992) Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176:1387-1398.
9. 9. Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, Wysocka M, Trinchieri G, Murphy KM, O'Garra A (1995) Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 154:5071-5079.
10. 10. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf S F, Young D, Clark SC, Trinchieri G (1991) Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 173:869-879.
11. 11. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, OGarra A, Murphy KM (1993) Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547-549.
12. 12. Seder RA, Gazzinelli R, Sher A, Paul WE (1993) Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci USA 90:10188-10192.
13. 13. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S (1993) Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177:1199-1204.
14. 14. Wynn TA, Eltoum I, Oswald IP, Cheever AW, Sher A (1994) Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med 179:1551-1561.
15. 15. Gately MK, Warrier RR, Honasoge S, Carvajal DM, Faherty DA, Connaughton SE, Andersson TD, Sarmiento U, Hubbard BR, Murphy M (1994) Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo. Int Immunol 6:157-167.
16. 16. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK (1993) Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 177:1505-1509.
17. 17. Afonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P (1994) The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235-237.
18. 18. Tang YW, Graham BS (1995) Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. J Infect Dis 172:734-738.
19. 19. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK (1993) Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 178:1223-1230.
20. 20. Morein B, Sundquist B, Hoglund S, Dalsgaard K, Osterhaus A (1984) Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 308:457-460.
21. 21. Morein B, Lövgren K, Rönnberg B, Sjölander A, Villacres-Eriksson M (1995) Immunostimulating complexes: Clinical potential in vaccine development. Clin Immunother 3:461-475.
22. 22. Villacres-Eriksson M, Bergström-Mollaoglu M, Kåberg H, Morein B (1992) Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscoms. Scand J Immunol 36:421-426.
23. 23. Fossum C, Bergström M, Lövgren K, Watson DL, Morein B (1990) Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix. Cell Immunol 129:414-425.
24. 24. Lövgren K (1988) The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes. Scand J Immunol 27:241-245.
25. 25. Villacres-Eriksson M (1995) Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes. Clin Exp Immunol 102:46-52.
26. 26. Maloy KJ, Donachie AM, Mowat AM (1995) Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMs. Eur J Immunol 25:2835.
27. 27. Gillessen S, Carvajal D, Ling P, Podlaski FJ, Stremlo DL, Familletti PC, Gubler U, Presky DH, Stern AS, Gately MK (1995) Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol 25:200-206.
28. 28. Lövgren-Bengtsson K, Sjölander A (1996) Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvant. Vaccine: 8:753-760.
29. 29. Behboudi S, Morein B, Villacres-Eriksson M (1996) In vitro activation of antigen-presenting cells by adjuvants of defined composition using Quillaja saponaria Molina triterpenoids. Clin Exp Immunol: 105:26-30.
30. 30. Morris SC, Madden KB, Adamovicz JJ, Gause WC, Hubbard BR, Gately MK, Finkelman FD (1994) Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol 152:1047-1056.
31. 31. Germann T, Bongartz M, Dlugonska H, Hess H, Schmitt E, Kolbe L, Kolsch E, Podlaski FJ, Gately MK, Rude E (1995) Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur J Immunol 25:823-829.
32. 32. Finkelman FD, Katona IM, Mosmann TR, Coffman RL (1988) IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 140: 1022-1027.
33. 33. Shu U, Kiniwa M, Wu CY, Maliszewski C, Vezzio N, Hakimi J, Gately M, Delespesse G (1995) Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 25:1125-1128.
34. 34. Macatonia SE, Hsieh CS, Murphy KM, O'Garra A (1993) Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from alpha beta TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-gamma production is IFN-gamma-dependent. Int Immunol 5: 1119-1128.
35. 35. Hayglass KT, Stefura WP (1991) Antigen-specific inhibition of ongoing murine IgE responses. II. Inhibition of IgE responses induced by treatment with glutaraldehyde-modified allergens is paralleled by reciprocal increases in IgG2a synthesis. J Immunol 147:2455-2460.
36. 36. Scheicher C, Mehlig M, Dienes HP, Reske K (1995) Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1 alpha and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation. Eur J Immunol 25:1566-1572.
37. 37. Villacres-Eriksson M, Bergström-Mollaoglu M, Kåberg H, Lövgren K, Morein B (1993) The induction of cell-associated and secreted IL-1 by iscoms, matrix or micelles in murine splenic cells. Clin Exp Immunol 93:120-125.
38. 38. Villacres-Eriksson M (1993) PhD Thesis, Swedish University of Agricultural Sciences.
39. 39. Sundquist B, Lövgren K, Höglund S, Morein B (1988) Influenza virus iscoms: biochemical characterization. Vaccine 6:44-48.
40. 40. Vogel FR, Powell MF(1995) A compendium of vaccine adjuvants and excipients. In Powell & Newman (eds) Vaccine Design, Plenum Press, New York pp. 177-179.
41. 41. Conway M, Morgan A, Mackett M (1989) Expression of Epstein-Barr virus membrane antigen gp340/220 in mouse fibroblasts using a bovine papillomavirus vector. J Gen Virol 70:729-734.
42. 42. Wysocka M, Kubin M, Vieira L, Ozmen L, Garotta G, Scott O, Trinchieri G (1995) Interleukin-12 is required for interferon-g production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol 25:672-676.
43. 43. Spitalny GL, Havell EA (1984) Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J Exp Med 159:1560-1565.
44. 44. Ohara J, Paul WE (1985) Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315:333-336.
45. 45. Gately MK, Chizzonite R (1992) In Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds) Current Protocols in Immunology, Vol. 1, Wiley, New York 1992, pp. 6.16.1.